These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 11840032)
1. Ganciclovir treatment in infants with cytomegalovirus infection and cholestasis. Fischler B; Casswall TH; Malmborg P; Nemeth A J Pediatr Gastroenterol Nutr; 2002 Feb; 34(2):154-7. PubMed ID: 11840032 [TBL] [Abstract][Full Text] [Related]
2. Treatment of symptomatic congenital cytomegalovirus infection with intravenous ganciclovir followed by long-term oral valganciclovir. Amir J; Wolf DG; Levy I Eur J Pediatr; 2010 Sep; 169(9):1061-7. PubMed ID: 20232081 [TBL] [Abstract][Full Text] [Related]
3. Cytomegalovirus hepatitis and ganciclovir treatment in immunocompetent children. Tezer H; Seçmeer G; Kara A; Ceyhan M; Cengiz AB; Devrim I; Us D; Yüce A; Gürakan F; Yildirim I; Ozen H; Saltik-Temizel IN Turk J Pediatr; 2008; 50(3):228-34. PubMed ID: 18773667 [TBL] [Abstract][Full Text] [Related]
4. Perinatal cytomegalovirus hepatitis: to treat or not to treat with ganciclovir. Vancíková Z; Kucerová T; Pelikán L; Zikmundová L; Priglová M J Paediatr Child Health; 2004 Aug; 40(8):444-8. PubMed ID: 15265185 [TBL] [Abstract][Full Text] [Related]
5. Cholestasis caused by panhypopituitarism and acquired cytomegalovirus infection in a 2-month-old male infant: A case report. Chan U; Chan WT; Ting WH; Ho CS; Liu HC; Lee HC Medicine (Baltimore); 2017 Apr; 96(17):e6757. PubMed ID: 28445302 [TBL] [Abstract][Full Text] [Related]
6. Re: ganciclovir treatment in infants with cytomegalovirus infection and cholestasis. Jonas MM J Pediatr Gastroenterol Nutr; 2002 Sep; 35(3):399-400; author reply 400. PubMed ID: 12352538 [No Abstract] [Full Text] [Related]
7. Ganciclovir therapy for cytomegalovirus-associated liver disease in immunocompetent or immunocompromised children. Nigro G; Krzysztofiak A; Bartmann U; Clerico A; Properzi E; Valia S; Castello M Arch Virol; 1997; 142(3):573-80. PubMed ID: 9349303 [TBL] [Abstract][Full Text] [Related]
8. [Therapy Options for Infants with Congenital Cytomegalovirus Infection - Implications for Setting Up Neonatal Screening Programs]. Bührer C; Blankenstein O; Rossi R; Z Geburtshilfe Neonatol; 2020 Apr; 224(2):71-78. PubMed ID: 31426118 [TBL] [Abstract][Full Text] [Related]
10. Ganciclovir therapy in cytomegalovirus (CMV) infection in immunocompetent pediatric patients. Avila-Agüero ML; Paris MM; Alfaro W; Avila-Agüero CR; Faingezicht I Int J Infect Dis; 2003 Dec; 7(4):278-81. PubMed ID: 14656419 [TBL] [Abstract][Full Text] [Related]
11. Effect on hearing of ganciclovir therapy for asymptomatic congenital cytomegalovirus infection: four to 10 year follow up. Lackner A; Acham A; Alborno T; Moser M; Engele H; Raggam RB; Halwachs-Baumann G; Kapitan M; Walch C J Laryngol Otol; 2009 Apr; 123(4):391-6. PubMed ID: 18588736 [TBL] [Abstract][Full Text] [Related]
12. Neurodevelopmental outcomes following ganciclovir therapy in symptomatic congenital cytomegalovirus infections involving the central nervous system. Oliver SE; Cloud GA; Sánchez PJ; Demmler GJ; Dankner W; Shelton M; Jacobs RF; Vaudry W; Pass RF; Soong SJ; Whitley RJ; Kimberlin DW; J Clin Virol; 2009 Dec; 46 Suppl 4(Suppl 4):S22-6. PubMed ID: 19766534 [TBL] [Abstract][Full Text] [Related]
13. Ganciclovir therapy for symptomatic congenital cytomegalovirus infection in infants: a two-regimen experience. Nigro G; Scholz H; Bartmann U J Pediatr; 1994 Feb; 124(2):318-22. PubMed ID: 8301446 [TBL] [Abstract][Full Text] [Related]
14. The viral association of neonatal cholestasis in Sweden: a possible link between cytomegalovirus infection and extrahepatic biliary atresia. Fischler B; Ehrnst A; Forsgren M; Orvell C; Nemeth A J Pediatr Gastroenterol Nutr; 1998 Jul; 27(1):57-64. PubMed ID: 9669727 [TBL] [Abstract][Full Text] [Related]
15. Does valganciclovir hydrochloride (valcyte) provide effective prophylaxis against cytomegalovirus infection in liver transplant recipients? Jain A; Orloff M; Kashyap R; Lansing K; Betts R; Mohanka R; Menegus M; Ryan C; Bozorgzadeh A Transplant Proc; 2005 Sep; 37(7):3182-6. PubMed ID: 16213344 [TBL] [Abstract][Full Text] [Related]
16. [Cytomegalovirus cholestasis in an immunocompetent host]. Ouandaf A; Chergui H; Seffar M; Chocho Z; Marcil S; Ouazzani H; Kabbaj H Ann Biol Clin (Paris); 2019 Jun; 77(3):323-326. PubMed ID: 30977729 [TBL] [Abstract][Full Text] [Related]
17. [Clinical observation of cholestatic liver disease caused by cytomegalovirus infection treated by lidan mixture: a case report of 120 infants]. Yan SQ; Deng YP; Tang JQ Zhongguo Zhong Xi Yi Jie He Za Zhi; 2012 Dec; 32(12):1632-7. PubMed ID: 23469602 [TBL] [Abstract][Full Text] [Related]